Synthesis, In-vivo estimation of Novel 3-(6-Substituted Benzthiazole-2-yl /Oxadiazole-2-yl)-2-Substituted 4-Quinazolineones

Authors

  • Dinesh D. Rishipathak Department of Pharmaceutical Chemistry, MET’s Institute of Pharmacy, Bhujbal Knowledge City, Nashik-422003, Maharashtra, India
  • Yogita B. Thombare Department of Pharmaceutical Chemistry, MET’s Institute of Pharmacy, Bhujbal Knowledge City, Nashik-422003, Maharashtra, India
  • Ashutosh R. Gupta Department of Pharmaceutical Chemistry, MET’s Institute of Pharmacy, Bhujbal Knowledge City, Nashik-422003, Maharashtra, India
  • Kanchan S. Shinde Department of Pharmaceutical Chemistry, MET’s Institute of Pharmacy, Bhujbal Knowledge City, Nashik-422003, Maharashtra, India
  • Bhagyashri P. Jain Department of Pharmaceutical Chemistry, MET’s Institute of Pharmacy, Bhujbal Knowledge City, Nashik-422003, Maharashtra, India
  • Shantanu S. Ghodke Department of Pharmaceutical Chemistry, MET’s Institute of Pharmacy, Bhujbal Knowledge City, Nashik-422003, Maharashtra, India

DOI:

https://doi.org/10.25004/IJPSDR.2024.160217

Keywords:

Quinozalin-4(3H)-one, Oxadiazole, Benzothiazole, Anticonvulsant

Abstract

Even with all of the new and old therapies available, seizure management is infamously difficult. Scientists will continue to search for novel drugs with high selectivity and low central nervous system side effects in the hopes of finding the newest and most effective treatment. This work designates the synthesis of several 4- quinazolinones substituted with oxadiazoles and benzothiazoles through condensation of 2-substituted-4H-benzo(1,3)-oxazin-4-ones with substituted-oxadiazole and 6-substituted-benzothiazol-2-amine. The title compounds were confirmed through IR, 1H-NMR, 13C-NMR analyses. The compounds evaluated for   anticonvulsant activity. Compounds A3, A4, A9, A5, A10 possess good potential. They reduce the extent of tonic phase up to 1.3 to 1.1 seconds and stupor up to 100 to 51 seconds with absence of straub phase when compared to the control group.

Downloads

Download data is not yet available.

References

Sirven JI. Epilepsy: A Spectrum Disorder. Cold Spring Harbor perspectives in medicine. 2015; 5(9): a022848. Available from: https://doi.org/10.1101/cshperspect.a022848.

D'Antuono M, Köhling R, Ricalzone S, Gotman J, Biagini G, Avoli M. Antiepileptic drugs abolish ictal but not interictal epileptiform discharges in vitro. Epilepsia. 2010; 51(3):423-31. Available from: https://doi.org/10.1111/j.1528-1167.2009.02273.x

Nain S, Sharma A, Singh HO, Paliwal S. Recent Advances in use of Semicarbazones as Anticonvulsant Agents: A Review. Journal of Biomedical and Therapeutic Sciences. 2015; 2(1): 1-7.

Maruthamuthu R, Christina D, Bharathi R. The chemistry and biological significance of imidazole, benzimidazole, benzoxazole, tetrazole and quinazolinone nucleus. Journal of Chemical and Pharmaceutical Research. 2016; 8(5): 505-526.

Kaur H, Kumar S, Vishwakarma P, Sharma M, Saxena KK, Kumar A. ChemInform Abstract: Synthesis and Antipsychotic and Anticonvulsant Activity of Some New Substituted Oxa/Thiadiazolylazetidinonyl/Thiazolidinonylcarbazoles. European Journal of medicinal Chemistry. 2010; 45:2777-2783. Available from: https://doi.org/10.1016/j.ejmech.2010.02.060.

Abuelizz HA, Dib RE, Marzouk M, Anouar E-H, A. Maklad Y, N. Attia H, Al-Salahi R. Molecular Docking and Anticonvulsant Activity of Newly Synthesized Quinazoline Derivatives. Molecules. 2017; 22(7):1094. Available from: https://doi.org/10.3390/molecules22071094

Küçükgüzel SG, Oruç EE, Rollas S, Sahin F, Ozbek A. Synthesis, characterisation and biological activity of novel 4-thiazolidinones, 1,3,4-oxadiazoles and some related compounds. European Journal of Medicinal Chemistry. 2002;37(3):197-206. Available from: https://doi.org/10.1016/s0223-5234(01)01326-5.

Wang X, Hu H, Zhao X, Chen M, Zhang T, Geng C, Mei Y, Lu A, Yang C. Novel quinazolin-4(3H)-one derivatives containing a 1,3,4-oxadiazole thioether moiety as potential bactericides and fungicides: Design, synthesis, characterization and 3D-QSAR analysis. Journal of Saudi Chemical Society. 2016; 23(8): 1144-1156. Available from: https://doi.org/10.1016/j.jscs.2019.07.006.

Alsibaee AM, Al-Yousef HM, Al-Salem HS. Quinazolinones, the Winning Horse in Drug Discovery. Molecules. 2023;28(3):978. Available from: https://doi.org/10.3390/molecules28030978.

Foucourt A, Hédou D, Dubouilh-Benard C, Désiré L, Casagrande A-S, Leblond B, Loäec N, Meijer L, Besson T. Design and Synthesis of Thiazolo[5,4-f]quinazolines as DYRK1A Inhibitors, Part I. Molecules. 2014; 19(10):15546-15571. Avaibale form https://doi.org/10.3390/molecules191015546

Lanting X, Yongwen J, Dawei M. Synthesis of 3-Substituted and 2,3-Disubstituted Quinazolinones via Cu-Catalyzed Aryl Amidation. Organic Letters. 2012; 14(4): 1150–1153. Available from: https://doi.org/10.1021/ol300084v

Lin H, Haoquan L, Jianbin C, Xiao-Feng W. Recent advances in 4(3H)-quinazolinone syntheses. RSC Advances. 2014;4(24):12065-12077. Available from: https://doi.org/10.1039/C4RA00351A

Mahmoud MR, El-Shahawi MM, Abu El-Azm FSM. Synthesis of novel quinazolinone and fused quinazolinones. European Journal of Chemistry. 2011; 2(3):404-409. Available from: https://doi.org/10.5155/eurjchem.2.3.404-409.267.

Rishipathak DD, Patil KV, Wajpeyi PS, Daryani MJ. Design and molecular docking studies of some 1,3,4-thiadiazole derivatives. International Journal of Pharmaceutical Sciences and Research. 2016; 7(12): 5044-51. Available from: https://doi.org/10.13040/IJPSR.0975-8232.7(12).5044-51

Rishipathak DD, Karanjikar C, Udavant PB. Microwave Assisted Synthesis and Evaluation of Anticonvulsant Activity of Some 3-(3-(Substituted benzylidine)amino)phenyl-2-phenylquinazolin-4(3H)-ones. Asian Journal of Chemistry. 2023;35(1): 95–98. Available from: https://doi.org/10.14233/ajchem.2023.26877

Rishipathak DD, Vaidya S, Ghodke SS. Synthesis and Evaluation of Anticonvulsant Activity of Some 5,5-Disubstituted-N3-[(2-aryl thiazolidine-4-one-3-yl)amino]hydantoins. Asian Journal of Chemistry. 2023;35(3):591-597. Available from: https://doi.org/10.14233/ajchem.2023.27282

Downloads

Published

30-03-2024

Issue

Section

Research Article

How to Cite

“Synthesis, In-Vivo Estimation of Novel 3-(6-Substituted Benzthiazole-2-Yl Oxadiazole-2-Yl)-2-Substituted 4-Quinazolineones”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 16, no. 2, Mar. 2024, pp. 267-72, https://doi.org/10.25004/IJPSDR.2024.160217.